Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00427_DB00433_nanopub.RALXq8ibBRb8-LDRKHGQjEmnvzRRNiG6tXJn42NgWhfMY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00427_DB00433 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00427_DB00433 label "DDI between Triprolidine and Prochlorperazine - The antihistamine, Triprolidine, may increase the arrhythmogenic effect of the phenothiazine, Prochlorperazine. Monitor for symptoms of ventricular arrhythmias. Additive anticholinergic and CNS depressant effects may also occur. Monitor for enhanced anticholinergic and CNS depressant effects. [drugbank_resource:DB00427_DB00433]" assertion.
- drugbank_resource:DB00427_DB00433 identifier "drugbank_resource:DB00427_DB00433" assertion.
- drugbank_resource:DB00427_DB00433 title "DDI between Triprolidine and Prochlorperazine - The antihistamine, Triprolidine, may increase the arrhythmogenic effect of the phenothiazine, Prochlorperazine. Monitor for symptoms of ventricular arrhythmias. Additive anticholinergic and CNS depressant effects may also occur. Monitor for enhanced anticholinergic and CNS depressant effects." assertion.
- drugbank:DB00427 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00427_DB00433 assertion.
- drugbank:DB00433 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00427_DB00433 assertion.